{"id":"https://openalex.org/W4416670669","doi":"https://doi.org/10.1158/1078-0432.30709066","title":"Supplementary Table S2 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies","display_name":"Supplementary Table S2 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416670669","doi":"https://doi.org/10.1158/1078-0432.30709066"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30709066","doi":"https://doi.org/10.1158/1078-0432.30709066","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709066","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30709066","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079846889","display_name":"Jayastu Senapati","orcid":"https://orcid.org/0000-0002-6831-2567","observed_orcids":["https://orcid.org/0000-0002-6831-2567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayastu Senapati","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6831-2567","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067678169","display_name":"Warren C. Fiskus","orcid":"https://orcid.org/0000-0002-7343-6214","observed_orcids":["https://orcid.org/0000-0002-7343-6214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Warren C. Fiskus","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7343-6214","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7103-373X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062684149","display_name":"Nathaniel R. Wilson","orcid":"https://orcid.org/0000-0002-9123-1781","observed_orcids":["https://orcid.org/0000-0002-9123-1781"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathaniel R. Wilson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9123-1781","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7621-377X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3631-2482","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan Kadia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9892-9832","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9003-0390","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4465-6119","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058755419","display_name":"Jan A. Burger","orcid":"https://orcid.org/0000-0002-6177-7572","observed_orcids":["https://orcid.org/0000-0002-6177-7572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Burger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6177-7572","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2983-2738","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070065917","display_name":"Yesid Alvarado","orcid":"https://orcid.org/0000-0002-1652-7937","observed_orcids":["https://orcid.org/0000-0002-1652-7937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yesid Alvarado","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1652-7937","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0114-8384","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080350639","display_name":"Lucia Mas\u00e1rov\u00e1","orcid":"https://orcid.org/0000-0001-6624-4196","observed_orcids":["https://orcid.org/0000-0001-6624-4196"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucia Masarova","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6624-4196","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059600583","display_name":"Ghayas C. Issa","orcid":"https://orcid.org/0000-0002-4339-8683","observed_orcids":["https://orcid.org/0000-0002-4339-8683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ghayas C. Issa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4339-8683","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088821817","display_name":"Wei Qiao","orcid":"https://orcid.org/0000-0002-0922-0726","observed_orcids":["https://orcid.org/0000-0002-0922-0726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Qiao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0922-0726","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088881526","display_name":"Joseph David Khoury","orcid":"https://orcid.org/0000-0003-2621-3584","observed_orcids":["https://orcid.org/0000-0003-2621-3584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph D. Khoury","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2621-3584","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030500582","display_name":"Sherry A. Pierce","orcid":"https://orcid.org/0000-0002-9542-1558","observed_orcids":["https://orcid.org/0000-0002-9542-1558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherry Pierce","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9542-1558","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000855145","display_name":"Darla Miller","orcid":"https://orcid.org/0009-0001-3183-1654","observed_orcids":["https://orcid.org/0009-0001-3183-1654"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darla Miller","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-3183-1654","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029750735","display_name":"Koji Sasaki","orcid":"https://orcid.org/0000-0002-9140-0610","observed_orcids":["https://orcid.org/0000-0002-9140-0610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Sasaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9140-0610","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9347-2212","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kapil N. Bhalla","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5209-5126","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055045706","display_name":"Gautam M. Borthakur","orcid":"https://orcid.org/0000-0001-7679-6453","observed_orcids":["https://orcid.org/0000-0001-7679-6453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gautam Borthakur","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7679-6453","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1670-6513","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.5332000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.5332000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.4535999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hepatic-adverse-events","display_name":"hepatic adverse events","score":0.9120000004768372},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.8547000288963318},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7652000188827515},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.6632999777793884},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5534999966621399},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5521000027656555},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5242000222206116},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5224999785423279},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.46470001339912415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43230000138282776},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.42309999465942383},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3215000033378601},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3197000026702881},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28999999165534973},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.2766000032424927},{"id":"https://openalex.org/C2777357209","wikidata":"https://www.wikidata.org/wiki/Q3595842","display_name":"Phlebotomy","level":2,"score":0.2750000059604645},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.267300009727478}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709066","doi":"https://doi.org/10.1158/1078-0432.30709066","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709066","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709066","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Phase_I_Results_of_Bromodomain_and_Extra-Terminal_Inhibitor_PLX51107_in_Combination_with_Azacitidine_in_Patients_with_Relapsed_Refractory_Myeloid_Malignancies/30709066","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709066","doi":"https://doi.org/10.1158/1078-0432.30709066","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709066","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416629758","https://openalex.org/W4385858408","https://openalex.org/W4388112860","https://openalex.org/W3214495840","https://openalex.org/W4282049101","https://openalex.org/W4385217389","https://openalex.org/W4387263646","https://openalex.org/W4255012745","https://openalex.org/W4401878247","https://openalex.org/W4401875912"],"abstract_inverted_index":{"Hepatic":[0],"adverse":[1],"events":[2]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-25T00:00:00"}